|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's Range||25.39 - 26.26|
|52 Week Range||21.79 - 38.99|
|Beta (3Y Monthly)||1.63|
|PE Ratio (TTM)||23.64|
|Earnings Date||Oct 24, 2017 - Oct 30, 2017|
|Forward Dividend & Yield||0.34 (1.32%)|
|1y Target Est||28.57|
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
Today we'll take a closer look at LeMaitre Vascular, Inc. (NASDAQ:LMAT) from a dividend investor's perspective. Owning...
BURLINGTON, Mass., May 29, 2019 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Jefferies Healthcare.
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Tiger Global because we determined that some of the stocks that they are collectively bullish on can help us generate returns above the broader indices. Out of thousands of stocks that hedge funds invest in, small-caps […]
BURLINGTON, Mass., May 06, 2019 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in two investor conferences in May. David Roberts,.
LeMaitre (LMAT) delivered earnings and revenue surprises of -10.53% and 1.74%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
The Burlington, Massachusetts-based company said it had net income of 17 cents per share. The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment ...
BURLINGTON, Mass., May 01, 2019 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2019 results, provided.
BURLINGTON, Mass., April 24, 2019 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2019 financial results on Wednesday, May 1,.
Looking at LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) earnings update in December 2018, the consensus outlook from analysts appear somewhat bearish, with profits predicted to rise...
LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On the other...
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! LeMaitre Vascular, Inc. (NASDAQ:LMAT) is a stock with outstanding fundamentalRead More...
LeMaitre Vascular Inc provides medical devices and human tissue cryopreservation services for the treatment of peripheral vascular disease. The dividend yield of LeMaitre Vascular Inc stocks is 0.93%. LeMaitre Vascular Inc had annual average EBITDA growth of 27.70% over the past five years.
When LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) announced its latest earnings (31 December 2018), I wanted to understand how these figures stacked up against its past performance. The two benchmarks I usedRead More...
Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! Today we are going to look at LeMaitre Vascular, Inc.Read More...
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Feb. 19) Alector Inc (NASDAQ: ALEC ) (IPOed early February) ...